InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,456.96
(
0.47%
)
US TECH 100
19,242.40
(
0.39%
)
Dow Jones
38,692.73
(
0.27%
)
Brent Oil
83.18
(
1.28%
)
Bitcoin
65,690.57
(
-1.41%
)
Post# of 17459
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Transat 5

Send PM Follow Ignore
Followers 5
Posts 1090
Boards Moderated 0
Alias Born 02/15/2005

Transat 5

Re: None

Wednesday, 02/08/2006 6:05:43 PM

Wednesday, February 08, 2006 6:05:43 PM

Post# of 17459
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Feb. 8, 2006--GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced that it is unaware of any reason for the unusual trading activity today in its common stock. GTC does not expect to have any new announcement regarding its ATryn® submission to the European Medicines Agency before the conclusion of the meeting of the Committee for Medicinal Products for Human Use (CHMP) which takes place from February 20 through February 23.

GTCB lost 1/2 pps today.
No apparent reason.
Triggered/Caved through stop losses.

Another 10/% to recover ?

The prospect off an EU approval ?

JMO

GLTA





http://www.investigatethesec.com

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up